Cancer immunotherapy involves harnessing and enhancing the innate powers of the immune system to fight cancer. Researchers use many experimental methods to screen and evaluate immune cell‐mediated killing, but predicting treatment efficacy is a challenge. The technology is now available for monitoring cultured cell number, size, attachment, and migration in real time, facilitating researchers efforts to develop and test new immunotherapy approaches.
Download this eBook from Agilent Technologies to learn about real-time cell analysis for
The Scientist c/o LabX Media Group
1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801
Toll Free: 888.788.0328 | Phone: 705.528.6888
Email: privacy@the-scientist.com
© 1986-2022 The Scientist
The Scientist needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.